A top-secret US research facility that studies Sars-CoV-2, Ebola and other deadly pathogens has been shut down by the Trump ...

A team at UC San Francisco and Gladstone Institutes has developed new drug candidates that show great promise against the ...

The following is a summary of “Vitamin D Status and Incidence of SARS-CoV-2 Reinfections in the Borriana COVID-19 Cohort: A ...

The following is a summary of “Effect of pre-existing coronavirus antibodies on SARS-CoV-2 infection outcomes in exposed household members,” published in the April 2025 issue of Journal of Infectious ...

UCSF researchers designed new drug candidates that potently block MPro, a viral enzyme that's crucial for SARS-CoV-2 replication. One of these drug candidates, AVI-4516, is shown (center) bound to the ...

The White House has revamped its COVID-19 website to support the lab leak theory, claiming the virus originated from a ...

Get Instant Summarized Text (Gist) An AI-driven platform has been used to optimize an antibody, 3152-1142, to neutralize a wide range of SARS-CoV-2 variants, enhancing its potency against ...

The highest risk of transmission of SARS-CoV-2 was in the first 72 hours at room temperature and first 24 hours at 37℃.

As the Trump administration continues to rattle swords with US science, we speak with Lisa Fazio of Vanderbuilt University who found out abruptly her funding from the National Science Foundation is ...